Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Medical Devices industry

Radiopharmaceuticals In Nuclear Medical Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Code : SMI18051
  • Pages : 115
  • Date : Jan, 2020
  • Category : Medical Devices
  • Publisher : SMI
  • Format : CMI Insight PPT FormatSMI Insight PDF Format

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Radiopharmaceuticals In Nuclear Medical Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Radiopharmaceuticals In Nuclear Medical Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Radiopharmaceuticals In Nuclear Medical Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Bracco Imaging
  • Cambridge Isotope Laboratories
  • Cardinal Health
  • Covidien
  • Eczacibasi-Monrol
  • Fujifilm Holdings Corporation
  • GE Healthcare (Subsidiary Of General Electric Company)
  • IBA Group
  • Lantheus Medical Imaging
  • Nordion
  • Ntp Radioisotopes
  • Siemens Healthcare
  • Taiyo Nippon Sanso Corporation
  • Urenco Limited
  • Rotem Industries

By the Product Type, the market is primarily segmented into:

  • Diagnostic Radiopharmaceuticals
  • Therapy Radiopharmaceuticals
  • Enriched Stable Isotopes

By Applications, the market is segmented into:

  • Diagnostic Application
  • Therapeutic Application
  • Research
  • Pharmaceutical
  • Industrial

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Radiopharmaceuticals In Nuclear Medical Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Radiopharmaceuticals In Nuclear Medical Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Radiopharmaceuticals In Nuclear Medical Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Radiopharmaceuticals In Nuclear Medical Market

The Radiopharmaceuticals In Nuclear Medical Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Radiopharmaceuticals In Nuclear Medical Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Industry Overview of Radiopharmaceuticals in Nuclear Medical
1.1 Definition of Radiopharmaceuticals in Nuclear Medical
1.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medical Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Radiopharmaceuticals in Nuclear Medical Segment by Applications
1.3.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Comparison by Applications (2014-2025)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Industrial
1.4 Global Radiopharmaceuticals in Nuclear Medical Overall Market
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Revenue (2014-2025)
1.4.2 Global Radiopharmaceuticals in Nuclear Medical Production (2014-2025)
1.4.3 North America Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.4 Europe Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.5 China Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.6 Japan Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.7 Southeast Asia Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)
1.4.8 India Radiopharmaceuticals in Nuclear Medical Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical
2.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
2.4 Industry Chain Structure of Radiopharmaceuticals in Nuclear Medical

3 Development and Manufacturing Plants Analysis of Radiopharmaceuticals in Nuclear Medical
3.1 Capacity and Commercial Production Date
3.2 Global Radiopharmaceuticals in Nuclear Medical Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Radiopharmaceuticals in Nuclear Medical
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Radiopharmaceuticals in Nuclear Medical Production and Capacity Analysis
4.2 Radiopharmaceuticals in Nuclear Medical Revenue Analysis
4.3 Radiopharmaceuticals in Nuclear Medical Price Analysis
4.4 Market Concentration Degree

5 Radiopharmaceuticals in Nuclear Medical Regional Market Analysis
5.1 Radiopharmaceuticals in Nuclear Medical Production by Regions
5.1.1 Global Radiopharmaceuticals in Nuclear Medical Production by Regions
5.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions
5.2 Radiopharmaceuticals in Nuclear Medical Consumption by Regions
5.3 North America Radiopharmaceuticals in Nuclear Medical Market Analysis
5.3.1 North America Radiopharmaceuticals in Nuclear Medical Production
5.3.2 North America Radiopharmaceuticals in Nuclear Medical Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Radiopharmaceuticals in Nuclear Medical Import and Export
5.4 Europe Radiopharmaceuticals in Nuclear Medical Market Analysis
5.4.1 Europe Radiopharmaceuticals in Nuclear Medical Production
5.4.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Radiopharmaceuticals in Nuclear Medical Import and Export
5.5 China Radiopharmaceuticals in Nuclear Medical Market Analysis
5.5.1 China Radiopharmaceuticals in Nuclear Medical Production
5.5.2 China Radiopharmaceuticals in Nuclear Medical Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Radiopharmaceuticals in Nuclear Medical Import and Export
5.6 Japan Radiopharmaceuticals in Nuclear Medical Market Analysis
5.6.1 Japan Radiopharmaceuticals in Nuclear Medical Production
5.6.2 Japan Radiopharmaceuticals in Nuclear Medical Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Radiopharmaceuticals in Nuclear Medical Import and Export
5.7 Southeast Asia Radiopharmaceuticals in Nuclear Medical Market Analysis
5.7.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Production
5.7.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Radiopharmaceuticals in Nuclear Medical Import and Export
5.8 India Radiopharmaceuticals in Nuclear Medical Market Analysis
5.8.1 India Radiopharmaceuticals in Nuclear Medical Production
5.8.2 India Radiopharmaceuticals in Nuclear Medical Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Radiopharmaceuticals in Nuclear Medical Import and Export

6 Radiopharmaceuticals in Nuclear Medical Segment Market Analysis (by Type)
6.1 Global Radiopharmaceuticals in Nuclear Medical Production by Type
6.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Type
6.3 Radiopharmaceuticals in Nuclear Medical Price by Type

7 Radiopharmaceuticals in Nuclear Medical Segment Market Analysis (by Application)
7.1 Global Radiopharmaceuticals in Nuclear Medical Consumption by Application
7.2 Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application (2014-2019)

8 Radiopharmaceuticals in Nuclear Medical Major Manufacturers Analysis
8.1 Bracco Imaging
8.1.1 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.1.2 Bracco Imaging Product Introduction, Application and Specification
8.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Cambridge Isotope Laboratories
8.2.1 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.2.2 Cambridge Isotope Laboratories Product Introduction, Application and Specification
8.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cardinal Health
8.3.1 Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.3.2 Cardinal Health Product Introduction, Application and Specification
8.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Covidien
8.4.1 Covidien Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.4.2 Covidien Product Introduction, Application and Specification
8.4.3 Covidien Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eczacibasi-Monrol
8.5.1 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.5.2 Eczacibasi-Monrol Product Introduction, Application and Specification
8.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Fujifilm Holdings Corporation
8.6.1 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.6.2 Fujifilm Holdings Corporation Product Introduction, Application and Specification
8.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GE Healthcare (Subsidiary Of General Electric Company)
8.7.1 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.7.2 GE Healthcare (Subsidiary Of General Electric Company) Product Introduction, Application and Specification
8.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 IBA Group
8.8.1 IBA Group Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.8.2 IBA Group Product Introduction, Application and Specification
8.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Lantheus Medical Imaging
8.9.1 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.9.2 Lantheus Medical Imaging Product Introduction, Application and Specification
8.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Nordion
8.10.1 Nordion Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
8.10.2 Nordion Product Introduction, Application and Specification
8.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Ntp Radioisotopes
8.12 Siemens Healthcare
8.13 Taiyo Nippon Sanso Corporation
8.14 Urenco Limited
8.15 Rotem Industries

9 Development Trend of Analysis of Radiopharmaceuticals in Nuclear Medical Market
9.1 Global Radiopharmaceuticals in Nuclear Medical Market Trend Analysis
9.1.1 Global Radiopharmaceuticals in Nuclear Medical Market Size (Volume and Value) Forecast 2019-2025
9.2 Radiopharmaceuticals in Nuclear Medical Regional Market Trend
9.2.1 North America Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.2 Europe Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.3 China Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.4 Japan Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.5 Southeast Asia Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.2.6 India Radiopharmaceuticals in Nuclear Medical Forecast 2019-2025
9.3 Radiopharmaceuticals in Nuclear Medical Market Trend (Product Type)
9.4 Radiopharmaceuticals in Nuclear Medical Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Radiopharmaceuticals in Nuclear Medical Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures
Figure Picture of Radiopharmaceuticals in Nuclear Medical
Table Global Radiopharmaceuticals in Nuclear Medical Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Types in 2018
Figure Diagnostic Radiopharmaceuticals Product Picture
Figure Therapy Radiopharmaceuticals Product Picture
Figure Enriched Stable Isotopes Product Picture
Table Global Radiopharmaceuticals in Nuclear Medical Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Applications in 2018
Figure Diagnostic Application
Figure Therapeutic Application
Figure Research
Figure Pharmaceutical
Figure Industrial
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) (2014-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Production (K Units) (2014-2025)
Figure North America Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure Europe Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure China Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure Japan Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Figure India Radiopharmaceuticals in Nuclear Medical Market Size (Million USD) (2014-2025)
Table Radiopharmaceuticals in Nuclear Medical Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical in 2018
Figure Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
Figure Industry Chain Structure of Radiopharmaceuticals in Nuclear Medical
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Radiopharmaceuticals in Nuclear Medical Manufacturing Plants Distribution
Table Radiopharmaceuticals in Nuclear Medical Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Radiopharmaceuticals in Nuclear Medical Capacity (K Units) of Major Manufacturers (2014-2019)
Table Radiopharmaceuticals in Nuclear Medical Production (K Units) of Major Manufacturers (2014-2019)
Table Radiopharmaceuticals in Nuclear Medical Production Market Share of Major Manufacturers (2014-2019)
Figure Radiopharmaceuticals in Nuclear Medical Production Share by Manufacturers in 2018
Table Radiopharmaceuticals in Nuclear Medical Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Radiopharmaceuticals in Nuclear Medical Revenue Market Share of Major Manufacturers (2014-2019)
Figure Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers in 2018
Table Radiopharmaceuticals in Nuclear Medical Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Radiopharmaceuticals in Nuclear Medical Production by Regions 2014-2019 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Regions 2014-2019
Figure Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Regions in 2018
Table Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions 2014-2019 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions 2014-2019
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions in 2018
Table Global Radiopharmaceuticals in Nuclear Medical Consumption by Regions 2014-2019 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Regions 2014-2019
Figure North America Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table North America Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure China Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure China Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table China Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure India Radiopharmaceuticals in Nuclear Medical Production Growth Rate 2014-2019 (K Units)
Figure India Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2014-2019 (Million USD)
Table India Radiopharmaceuticals in Nuclear Medical Production, Consumption Import and Export (K Units)
Figure Global Consumption Radiopharmaceuticals in Nuclear Medical Market Share by Application (2014-2019)
Figure Global Value (Consumption) Radiopharmaceuticals in Nuclear Medical Market Share by Application (2014-2019)
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Bracco Imaging Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Cardinal Health Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Covidien Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Covidien Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Covidien Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Covidien Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Covidien Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Covidien Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Covidien Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table IBA Group Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table IBA Group Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table IBA Group Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table IBA Group Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table IBA Group Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure IBA Group Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table IBA Group Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Nordion Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Nordion Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
Table Nordion Radiopharmaceuticals in Nuclear Medical Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Nordion Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2014-2019)
Table Nordion Radiopharmaceuticals in Nuclear Medical Production Market Share (2014-2019)
Figure Nordion Radiopharmaceuticals in Nuclear Medical Revenue Market Share (2014-2019)
Table Nordion Radiopharmaceuticals in Nuclear Medical Main Business and Markets Served
Table Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Urenco Limited Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Table Rotem Industries Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
Figure Global Radiopharmaceuticals in Nuclear Medical Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Radiopharmaceuticals in Nuclear Medical Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Radiopharmaceuticals in Nuclear Medical by Type (2019-2025)
Table Global Consumption (K Units) of Radiopharmaceuticals in Nuclear Medical by Application (2019-2025)
Table Radiopharmaceuticals in Nuclear Medical Distributors List
Table Radiopharmaceuticals in Nuclear Medical Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (thousand ton / metric ton / cubic meter).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us